AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 143 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $70,910,067 | -39.8% | 11,114,431 | +4.6% | 0.01% | -40.0% |
Q2 2023 | $117,807,558 | -29.2% | 10,622,864 | -2.0% | 0.01% | +25.0% |
Q1 2023 | $166,365,040 | +52.2% | 10,838,114 | +120.0% | 0.01% | -27.3% |
Q4 2022 | $109,294,139 | +92.7% | 4,925,378 | +41.8% | 0.01% | +83.3% |
Q3 2022 | $56,703,000 | +2.4% | 3,472,319 | -8.8% | 0.01% | 0.0% |
Q2 2022 | $55,347,000 | -21.4% | 3,809,123 | -0.0% | 0.01% | 0.0% |
Q1 2022 | $70,387,000 | -21.6% | 3,810,915 | +0.9% | 0.01% | -14.3% |
Q4 2021 | $89,768,000 | -4.9% | 3,776,524 | -1.5% | 0.01% | 0.0% |
Q3 2021 | $94,423,000 | +12.6% | 3,833,667 | +12.9% | 0.01% | 0.0% |
Q2 2021 | $83,874,000 | +12.0% | 3,394,315 | -1.1% | 0.01% | +16.7% |
Q1 2021 | $74,887,000 | -14.3% | 3,433,588 | +0.3% | 0.01% | -25.0% |
Q4 2020 | $87,383,000 | +2.8% | 3,424,135 | +13.4% | 0.01% | -11.1% |
Q3 2020 | $84,980,000 | +6.2% | 3,018,831 | +6.6% | 0.01% | 0.0% |
Q2 2020 | $80,056,000 | – | 2,832,852 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |